Sign in
Taking peopleNo phase

Medico-economic Evaluation of Immediately Sequential Bilateral Cataract Surgery Compared With Delayed Sequential Cataract Surgery in France

Key facts

Who runs it
Fondation Ophtalmologique Adolphe de Rothschild
Where
France4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
242 people, planned
Started
3 Jul 2025
Expected to end
Jul 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Immediatly sequential bilateral cataract surgery
  • Delayed sequential bilateral cataract surgery
Record updated
3 December 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Age greater than or equal to 18 years
  • Indication for non-combined cataract surgery under local anaesthesia in both eyes
  • Patient scheduled for outpatient cataract surgery
  • Availability of a caregiver/accompanying person on the day of surgery and for the 1st day post-surgery
  • Resident in France
  • Speak and understand French
  • Consent to participate in the study
  • Affiliated or beneficiary of social security

Who cannot take part

  • Surgery scheduled under general anesthesia or combined with other eye surgeries
  • Presence of risk factors for refractive error :; Presence of keratoconus confirmed by corneal topography Extreme axial eye length (< 21 mm or > 27 mm) High myopia with posterior staphyloma History of corneal surgery (LASIK, surface laser, radial keratotomy)
  • Presence of risk factors for endophthalmitis : Ocular, periocular or adnexal infections Immunosuppression Uncontrolled diabetes
  • Presence of risk factors for intraoperative complications Ocular, adnexal or anatomical abnormalities History of retinal detachment Lens dislocation or iridodonesis Black cataract or posterior polar cataract History of perforating or blunt ocular trauma
  • Presence of diabetes with diabetic retinopathy or macular edema
  • Presence of cognitive disorders that could affect the smooth running of surgery or response to questionnaires
  • Women of childbearing age
  • Ocular tone > 24 mm Hg in at least one eye on day of inclusion
  • Presence of risk factors for corneal edema (e.g. Fuchs' endothelial dystrophy)
  • Presence of vision-related comorbidities (glaucoma, AMD, amblyopia, uveitis, etc.)
  • Patient unable to participate in follow-up (e.g., response to questionnaires)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Cataracts are defined as opacification of all or part of the crystalline lens, resulting in reduced vision. It is a common disease in France, affecting more than one in five people over the age of 65, and almost two in three over the age of 85. Cataract treatment is exclusively surgical. In the case of bilateral cataracts, which account for 70% of cases, Delayed Sequential Bilateral Cataract Surgery (DSBCS), which involves operating on both eyes with an interval of a few weeks, is the reference treatment in France. The practice of DSBCS has long been justified by the need to reduce the risk of post-operative complications, essentially refractive error and bilateral endophthalmitis. Today, thanks to numerous technological advances in cataract surgery and new intraoperative standards, these complications have become exceptional. Since 2009, the International Society of Bilateral Cataract Surgeons (ISBCS) has issued a guide to best practice (the ''ISBCS General Principles for Excellence in ISBCS''), enabling surgery on both eyes to be performed on the same day in complete safety. As a result, Immediate Sequential Bilateral Cataract Surgery (ISBCS), which involves operating on both eyes on the same day, could be performed with no additional risk compared to SDBCS, while providing the same level of postoperative visual acuity. In view of these factors, we hypothesize that CCBIS would be an efficient alternative to DSBCS in cases of bilateral cataract, for the patient and his family, the hospital and the health insurance company. In addition, its adoption would reduce delays in access to treatment, thus promoting better access to care in the situation of growing demand for this treatment, particularly in areas with fewer medical facilities.

Read full original descriptionShow less

The aim of thisproject is to evaluate the associated costs and quality of life in comparison with CCBSD, based on a prospective, multicenter, randomized controlled trial.

The 2 groups in the trial

  • ISBCSTreatment being tested

    Both eyes will be operated on during the same surgical procedure. Surgery will be performed in accordance with the iSBCS (International Society of Bilateral Cataract Surgeons) General Principles for Excellence in ISBCS (Immediate Sequential Bilateral Cataract Surgery) \[12\] by investigating ophthalmic surgeons or co-investigators with at least two years' experience in cataract surgery.

    Treatment: Immediatly sequential bilateral cataract surgery

  • DSBCSExisting treatment, for comparison

    Only one eye will be operated on during the first surgiczal procedure. The second eye will be operated on during a second surgical procdure delayed from 3 weeks +/- 1 week. Surgeries will be performed according to current guidelines by investigating or co-investigating ophthalmic surgeons with at least two years' experience in cataract surgery.

    Treatment: Delayed sequential bilateral cataract surgery

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Medico-economic Evaluation of Immediately Sequential Bilateral Cataract Surgery Compared With Delayed Sequential Cataract Surgery in France: a Multicenter Randomized Controlled Trial
Record updated
3 December 2025